In summary, the HuDo-CSPG4 vaccine has been shown to be safe and effective in inducing anti-CSPG4 immunity in dogs affected by osteosarcoma, leading to prolonged survival compared to control groups. This evidence concerns the gene CSPG4 and osteosarcoma.